News
-
-
-
-
COMMUNIQUÉ DE PRESSE
MindMaze Therapeutics Provides Corporate Update and Publishes March 2026 Investor Presentation
MindMaze Therapeutics provides corporate update and publishes March 2026 investor presentation, focusing on expansion in the US and Europe, organizational restructuring, and governance changes -
-
-
COMMUNIQUÉ DE PRESSE
MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
MindMaze Therapeutics Holding SA outlines a global reimbursement strategy for next-generation neurotherapeutics, focusing on scalability and sustainable growth across major healthcare systems -
-
-
COMMUNIQUÉ DE PRESSE
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
Relief Therapeutics and NeuroX complete business combination forming MindMaze Therapeutics. Newly integrated entity aims to redefine neurological care with digital treatments and AI-powered solutions